NuStem

NuStem is a clinical-stage biotechnology company specializing in the development of neural stem cell-based therapies for central nervous system (CNS) disorders. The company leverages its proprietary platform to produce high-purity, clinical-grade neural stem cells designed to repair damaged neural tissue and restore function in patients with neurodegenerative conditions. Its lead programs target high-unmet-need indications such as amyotrophic lateral sclerosis (ALS) and spinal cord injury. NuStem's approach focuses on the regenerative potential of stem cells to provide long-term therapeutic benefits and improve quality of life for patients suffering from debilitating neurological diseases.